Zobrazeno 1 - 10
of 226
pro vyhledávání: '"Arkadiusz Z Dudek"'
Publikováno v:
Transplant International, Vol 37 (2024)
Immune checkpoint inhibitor (ICI) therapy has enabled a paradigm shift in Oncology, with the treatment of metastatic cancer in certain tumor types becoming akin to the treatment of chronic disease. Kidney transplant recipients (KTR) are at increased
Externí odkaz:
https://doaj.org/article/c3420592af204653b892e2aec3473fa5
Autor:
Steven F Powell, Arkadiusz Z Dudek
Publikováno v:
Pharmacogenomics and Personalized Medicine, Vol 2009, Iss default, Pp 21-37 (2009)
Steven F Powell1, Arkadiusz Z Dudek21Department of Medicine, University of Minnesota, Minneapolis, MN, USA; 2Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USAAbstract: Pemetrexed (ALIMTA, LY231514, MT
Externí odkaz:
https://doaj.org/article/962cf97ae2e64883a68741f450dbea27
Autor:
Ugur Sener, Mason Webb, William G. Breen, Bryan J. Neth, Nadia N. Laack, David Routman, Paul D. Brown, Anita Mahajan, Kelsey Frechette, Arkadiusz Z. Dudek, Svetomir N. Markovic, Matthew S. Block, Robert R. McWilliams, Anastasios Dimou, Lisa A. Kottschade, Heather N. Montane, Sani H. Kizilbash, Jian L. Campian
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 1, Pp 1-6 (2024)
Introduction Proton craniospinal irradiation (pCSI) is a treatment option for leptomeningeal disease (LMD), which permits whole neuroaxis treatment while minimizing toxicity. Despite this, patients inevitably experience progression. Adding systemic t
Externí odkaz:
https://doaj.org/article/e46cf582bd95407aa5330e020924b4ae
Autor:
Albert C Sek, Zhihui Xie, Kaoru Terai, Lauren M Long, Celeste Nelson, Arkadiusz Z Dudek, Kirk M Druey
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133266 (2015)
Idiopathic systemic capillary leak syndrome (SCLS) is a rare and potentially fatal vascular disorder characterized by reversible bouts of hypotension and edema resulting from fluid and solute escape into soft tissues. Although spikes in permeability-
Externí odkaz:
https://doaj.org/article/3e179512b00a4ccbab14894d4edda239
Correction: Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome.
Autor:
Albert C Sek, Zhihui Xie, Kaoru Terai, Lauren M Long, Celeste Nelson, Arkadiusz Z Dudek, Kirk M Druey
Publikováno v:
PLoS ONE, Vol 10, Iss 9, p e0137373 (2015)
Externí odkaz:
https://doaj.org/article/fd90a774d94841d782d3ad2d29a72353
Autor:
Kun Wang, Vidya Bodempudi, Zhengian Liu, Emma Borrego-Diaz, Farnaz Yamoutpoor, Anna Meyer, Richard A Woo, Weihong Pan, Arkadiusz Z Dudek, Mojtaba S Olyaee, Tuba Esfandyari, Faris Farassati
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e33214 (2012)
Mesothelin, a differentiation antigen present in a series of malignancies such as mesothelioma, ovarian, lung and pancreatic cancer, has been studied as a marker for diagnosis and a target for immunotherapy. We, however, were interested in evaluating
Externí odkaz:
https://doaj.org/article/00ea7089c1a64575811513a0a57777f5
Autor:
Arkadiusz Z. Dudek, MD, PhD, Min X. Xi, PhD, Katherine A. Scilla, MD, Hirva Mamdani, MD, Benjamin C. Creelan, MD, Andreas Saltos, MD, Tawee Tanvetyanon, MD, Alberto Chiappori, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100584- (2023)
Introduction: We hypothesized that ramucirumab could increase previously reported objective response rate (ORR) of 11% of single-agent nivolumab in the second-line therapy of unresectable mesothelioma. Methods: This was a cooperative group, single-ar
Externí odkaz:
https://doaj.org/article/0149c45692094f848ef9ee464ffa82d8
Autor:
Katherine E. R. Smith, Kah-Whye Peng, Jose S. Pulido, Adam J. Weisbrod, Carrie A. Strand, Jacob B. Allred, Alysha N. Newsom, Lianwen Zhang, Nandakumar Packiriswamy, Timothy Kottke, Jason M. Tonne, Madelyn Moore, Heather N. Montane, Lisa A. Kottschade, Robert R. McWilliams, Arkadiusz Z. Dudek, Yiyi Yan, Anastasios Dimou, Svetomir N. Markovic, Mark J. Federspiel, Richard G. Vile, Roxana S. Dronca, Matthew S. Block
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionMetastatic uveal melanoma (MUM) has a poor prognosis and treatment options are limited. These patients do not typically experience durable responses to immune checkpoint inhibitors (ICIs). Oncolytic viruses (OV) represent a novel approach
Externí odkaz:
https://doaj.org/article/0a92140d4f6e43bc9b4331d5a320712f
Autor:
Logan C. Tyler, Anh T. Le, Nan Chen, Hala Nijmeh, Liming Bao, Timothy R. Wilson, David Chen, Brian Simmons, Kristen M. Turner, Dean Perusse, Shailaja Kasibhatla, Jason Christiansen, Arkadiusz Z. Dudek, Robert C. Doebele
Publikováno v:
Thoracic Cancer, Vol 13, Iss 21, Pp 3032-3041 (2022)
Abstract Background ROS1 tyrosine kinase inhibitors (TKIs) have demonstrated significant clinical benefit for ROS1+ NSCLC patients. However, TKI resistance inevitably develops through ROS1 kinase domain (KD) modification or another kinase driving byp
Externí odkaz:
https://doaj.org/article/69b9447303ff45faa281860090224996
Autor:
Thomas A. Hensing, MD, MS, Xiaofei Wang, PhD, Thomas E. Stinchcombe, MD, Junheng Gao, MS, Michael V. Knopp, MD, PhD, Mark Watson, MD, PhD, Arkadiusz Z. Dudek, MD, PhD, Stephen L. Graziano, MD, Jyoti D. Patel, MD, Bryan A. Faller, MD, Konstantin H. Dragnev, MD, David Kozono, MD, PhD, Everett E. Vokes, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100208- (2021)
Introduction: The sequence of chemotherapy and pembrolizumab may affect antitumor immune response and efficacy of immunotherapy. Methods: This multicenter, randomized, phase 2 trial was designed to evaluate the efficacy of two sequences of chemothera
Externí odkaz:
https://doaj.org/article/df3a2223967b484e8c1430c2888b54cb